Conexeu Sciences Revenue

Biotechnology Research • Vancouver, British Columbia, Canada • 1-10 Employees

Conexeu Sciences revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Conexeu Sciences

David Bogart

Director, Founder

Company overview

Headquarters	Vancouver , BC V6E 4E5, CA
Phone number	+17025138856
Website	conexeu.com
NAICS	541714
Founded	2023
Employees	1-10
Socials

Conexeu Sciences Email Formats

Conexeu Sciences uses 2 email formats. The most common is {first name} (e.g., john@conexeu.com), used 66.7% of the time.

Format	Example	Percentage
{first name}	john@conexeu.com	66.7%
{first name}{last name}	johndoe@conexeu.com	33.3%

About Conexeu Sciences

Conexeu is building a new class of aesthetic and wound care products from our innovative tissue research in regenerative medicine. Our patented CXU Scaffold Technology is a groundbreaking advancement in regenerative medicine. The company is leading the development and commercialization of cellular therapies for skin regeneration. Conexeu’s first product Ten-Minute-Tissue™, is a liquid skin substitute which begins to transform and gel in the body, in about ~10 minutes. Inside the scaffold environment cells thrive and remodel into native tissue. Ideal for applications in wound care like burns, acute wounds and diabetic ulcers, with aesthetic indications for soft tissue fillers. The Ten-Minute-Tissue™ harnessesthe regenerative properties of a patient’s own tissue cells for significantly faster wound closure and integration within the wound margins and fewer complications. It delivers enhanced patient outcomes with faster wound healing, minimizing complications, and reducing recovery times. Conexeu is leveraging its proven and differentiated capabilities to develop first-in-class cellular therapies for multiple indications in Aesthetics and Wound care markets, with indications for; • Diabetic Ulcer Treatment • Acute Care Wounds • Chronic Wounds • Derm-Filler and Soft Tissue Injectables market.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Conexeu Sciences has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Conexeu Sciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-01-01	3	N/A

Funding Insights

Number of funding rounds

Conexeu Sciences Tech Stack

Discover the technologies and tools that power Conexeu Sciences's digital infrastructure, from frameworks to analytics platforms.

GoDaddy

Hosting

GoDaddy Website Builder

CMS

Open Graph

Miscellaneous

HSTS

Security

RequireJS

JavaScript frameworks

React

JavaScript frameworks

PWA

Miscellaneous

Frequently asked questions

Conexeu Sciences is located in Vancouver, British Columbia, CA.

You can reach Conexeu Sciences at +17025138856.

Conexeu Sciences generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Conexeu Sciences has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Conexeu Sciences was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Conexeu Sciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Conexeu Sciences

David Bogart

Director, Founder

4.8

40,000 users